Experimental investigation of the efficacy of pirfenidone in prevention of ostium cicatricial closure after dacryocystorhinostomy

Pirfenidone: A Promising Drug in Ocular Therapeutics

“…[12,13] These studies have shown its potential in promoting the healing of corneal wounds, treating ocular trauma, reducing corneal fibrosis and inflammation, preserving visual clarity, managing age-related macular degeneration (AMD), addressing proliferative vitreoretinopathy, and playing a prominent role in postoperative glaucoma surgery (Figure 2). [14][15][16][17][18][19][20][21] In recent years, pirfenidone has gained immense popularity and has been the subject of numerous research publications and patented technologies in ophthalmology. In this review, our focus is on systematically compiling the research conducted and the patented technologies developed, highlighting their significance and applications comprehensively.…”

“…These studies have shown its potential in promoting the healing of corneal wounds, treating ocular trauma, reducing corneal fibrosis and inflammation, preserving visual clarity, managing age‐related macular degeneration (AMD), addressing proliferative vitreoretinopathy, and playing a prominent role in postoperative glaucoma surgery (Figure 2). [14–21] …”